ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2013, Vol. 22 ›› Issue (5): 455-460.

• 论文 • 上一篇    下一篇

抗溶酶体膜蛋白-2抗体在ANCA相关血管炎肾损害中的研究进展

  

  • 出版日期:2013-10-28 发布日期:2013-10-28

Advances in Anti–LAMP-2 autoantibody and ANCA-associated pauci immun glomerulonephritis

  • Online:2013-10-28 Published:2013-10-28

摘要:

摘要    抗中性粒细胞胞浆抗体(ANCA)相关血管炎是继发性肾损害的重要病因之一,发病率及致死率均较高,且病情容易反复复发,治疗困难,其发病机制目前并不十分清楚。深入研究ANCA相关血管炎致病原因及发病机制是提高疗效的重要方法,而抗溶酶体膜蛋白-2(LAMP-2)抗体作为新发现的ANCA抗体,与ANCA相关血管炎的关系成为目前研究的焦点之一。虽然目前研究结果并不一致,但随着细菌感染、FimH与LAMP-2分子模拟、动物实验、人体实验观察的进一步深入,抗LAMP-2抗体将可能进一步揭示ANCA相关血管炎肾损害发病机制,并可能成为ANCA相关血管炎诊断、监测病情活动的新的标志,为免疫抑制剂个体化治疗提供依据.本文就抗- LAMP-2抗体与AASV肾损害的研究进展做一综述。

关键词:  关键词        , 抗溶酶体膜蛋白-2抗体   , 分子模拟      , ANCA相关血管炎    , 发病机制 

Abstract:

Abstract: ANCA-associated vasculitis is one of the most important reason for secondary renal injury, which has considerable morbidity and mortality and difficulty in treatment and easy to relapse because of its unclear pathogenicity. Anti–LAMP-2 Autoantibody is a new Anti-neutrophil Cytoplasmic Antibody. The relationship between AASV and Anti–LAMP-2 Autoantibody has become the focus of intense clinical interest at present. The further research in bacterial infection、molecular mimicry between hLAMP-2 and the bacterial protein FimH and Clinical and experimental studies in spite of the different results, pathogenesis mechanisms in patient with ANCA-associated vasculitis will be more understood. Anti–LAMP-2 Autoantibody probably will be a new biomarker for diagnosis and monitor in disease activity, and provide the basis in tailoring immunosuppression of the individual patient. In this article, the advances in Anti–LAMP-2 Autoantibodies and ANCA-Associated Pauci-immun glomerulonephritis are reviewed.

Key words: Key words  , Anti–LAMP-2 Autoantibody   , molecular mimicry , ANCA-associated vacuities   , pathogenesis mechanis